25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

INTS (Intensity Therapeutics, Inc. Common stock) Stock Analysis
Buy, Hold or Sell?

Let's analyze Intensity Therapeutics, Inc. Common stock together

I guess you are interested in Intensity Therapeutics, Inc. Common stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Intensity Therapeutics, Inc. Common stock’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Intensity Therapeutics, Inc. Common stock’s Price Targets

I'm going to help you getting a better view of Intensity Therapeutics, Inc. Common stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Intensity Therapeutics, Inc. Common stock

I send you an email if I find something interesting about Intensity Therapeutics, Inc. Common stock.

1. Quick Overview

1.1. Quick analysis of Intensity Therapeutics, Inc. Common stock (30 sec.)










1.2. What can you expect buying and holding a share of Intensity Therapeutics, Inc. Common stock? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.9%

What is your share worth?

Current worth
$0.19
Expected worth in 1 year
$-0.49
How sure are you?
35.3%

+ What do you gain per year?

Total Gains per Share
$-0.68
Return On Investment
-34.4%

For what price can you sell your share?

Current Price per Share
$1.97
Expected price per share
$1.5 - $2.5322
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Intensity Therapeutics, Inc. Common stock (5 min.)




Live pricePrice per Share (EOD)
$1.97
Intrinsic Value Per Share
$-5.40 - $-6.23
Total Value Per Share
$-5.20 - $-6.04

2.2. Growth of Intensity Therapeutics, Inc. Common stock (5 min.)




Is Intensity Therapeutics, Inc. Common stock growing?

Current yearPrevious yearGrowGrow %
How rich?$2.9m$7m-$1.8m-36.0%

How much money is Intensity Therapeutics, Inc. Common stock making?

Current yearPrevious yearGrowGrow %
Making money-$4m-$2.6m-$1.4m-35.2%
Net Profit Margin0.0%-280.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Intensity Therapeutics, Inc. Common stock (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Intensity Therapeutics, Inc. Common stock?

Welcome investor! Intensity Therapeutics, Inc. Common stock's management wants to use your money to grow the business. In return you get a share of Intensity Therapeutics, Inc. Common stock.

First you should know what it really means to hold a share of Intensity Therapeutics, Inc. Common stock. And how you can make/lose money.

Speculation

The Price per Share of Intensity Therapeutics, Inc. Common stock is $1.97. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Intensity Therapeutics, Inc. Common stock.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Intensity Therapeutics, Inc. Common stock, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.19. Based on the TTM, the Book Value Change Per Share is $-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is $0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Intensity Therapeutics, Inc. Common stock.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.21-10.7%-0.27-13.7%-0.17-8.9%-0.16-8.2%-0.16-8.2%
Usd Book Value Change Per Share0.010.5%-0.17-8.6%0.4723.7%0.010.6%0.010.6%
Usd Dividend Per Share0.000.0%0.000.0%0.021.1%0.010.3%0.010.3%
Usd Total Gains Per Share0.010.5%-0.17-8.6%0.4924.9%0.020.8%0.020.8%
Usd Price Per Share1.76-3.92-4.63-2.01-2.01-
Price to Earnings Ratio-2.09--3.55--5.68--2.17--2.17-
Price-to-Total Gains Ratio191.26-32.26--3.60-16.89-16.89-
Price to Book Ratio9.11-12.95-4.89-4.20-4.20-
Price-to-Total Gains Ratio191.26-32.26--3.60-16.89-16.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.97
Number of shares507
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.170.01
Usd Total Gains Per Share-0.170.02
Gains per Quarter (507 shares)-85.968.38
Gains per Year (507 shares)-343.8433.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-344-354102324
20-688-698214658
30-1032-1042316992
40-1375-13864292126
50-1719-173052115160
60-2063-207463138194
70-2407-241873161228
80-2751-276284184262
90-3095-310694207296
100-3438-3450105230330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%6.011.00.035.3%6.011.00.035.3%6.011.00.035.3%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.016.05.9%1.00.016.05.9%1.00.016.05.9%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%6.011.00.035.3%6.011.00.035.3%6.011.00.035.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Intensity Therapeutics, Inc. Common stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.009-0.170+1942%0.468-98%0.011-19%0.011-19%
Book Value Per Share--0.1930.344-44%0.467-59%-0.031+116%-0.031+116%
Current Ratio--1.9162.577-26%8.224-77%3.229-41%3.229-41%
Debt To Asset Ratio--0.3900.364+7%4.560-91%3.065-87%3.065-87%
Debt To Equity Ratio--0.6390.603+6%0.144+344%0.176+263%0.176+263%
Dividend Per Share----0%0.022-100%0.005-100%0.005-100%
Enterprise Value--27309448.00062180816.000-56%100622468.000-73%78655809.714-65%78655809.714-65%
Eps---0.211-0.269+28%-0.174-17%-0.162-23%-0.162-23%
Ev To Ebitda Ratio---2.146-3.713+73%-12.321+474%-7.402+245%-7.402+245%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.177-0.252+43%-0.119-32%-0.135-24%-0.135-24%
Free Cash Flow To Equity Per Share---0.013-0.204+1504%0.220-106%-0.028+118%-0.028+118%
Gross Profit Margin--1.0001.0010%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.234--------
Intrinsic Value_10Y_min---5.397--------
Intrinsic Value_1Y_max---0.614--------
Intrinsic Value_1Y_min---0.603--------
Intrinsic Value_3Y_max---1.853--------
Intrinsic Value_3Y_min---1.769--------
Intrinsic Value_5Y_max---3.102--------
Intrinsic Value_5Y_min---2.878--------
Market Cap29756456.000+11%26584448.00059210816.000-55%69859700.000-62%30369533.176-12%30369533.176-12%
Net Profit Margin----0%-2.8090%-0.6610%-0.6610%
Operating Margin----0%-2.8090%-0.6610%-0.6610%
Operating Ratio----0%2.970-100%0.699-100%0.699-100%
Pb Ratio10.198+11%9.11112.950-30%4.888+86%4.197+117%4.197+117%
Pe Ratio-2.339-12%-2.089-3.546+70%-5.680+172%-2.171+4%-2.171+4%
Price Per Share1.970+11%1.7603.920-55%4.625-62%2.011-12%2.011-12%
Price To Free Cash Flow Ratio-2.788-12%-2.491-3.753+51%-32.825+1218%-8.606+245%-8.606+245%
Price To Total Gains Ratio214.075+11%191.25532.257+493%-3.605+102%16.887+1033%16.887+1033%
Quick Ratio--1.4762.747-46%11.315-87%3.974-63%3.974-63%
Return On Assets---0.665-0.571-14%-0.482-27%-0.543-18%-0.543-18%
Return On Equity---1.090-0.939-14%-0.158-86%-0.258-76%-0.258-76%
Total Gains Per Share--0.009-0.170+1942%0.490-98%0.017-44%0.017-44%
Usd Book Value--2918000.0005191000.000-44%7061046.500-59%-791605.529+127%-791605.529+127%
Usd Book Value Change Per Share--0.009-0.170+1942%0.468-98%0.011-19%0.011-19%
Usd Book Value Per Share--0.1930.344-44%0.467-59%-0.031+116%-0.031+116%
Usd Dividend Per Share----0%0.022-100%0.005-100%0.005-100%
Usd Enterprise Value--27309448.00062180816.000-56%100622468.000-73%78655809.714-65%78655809.714-65%
Usd Eps---0.211-0.269+28%-0.174-17%-0.162-23%-0.162-23%
Usd Free Cash Flow---2668000.000-3805000.000+43%-1801250.000-32%-2144024.000-20%-2144024.000-20%
Usd Free Cash Flow Per Share---0.177-0.252+43%-0.119-32%-0.135-24%-0.135-24%
Usd Free Cash Flow To Equity Per Share---0.013-0.204+1504%0.220-106%-0.028+118%-0.028+118%
Usd Market Cap29756456.000+11%26584448.00059210816.000-55%69859700.000-62%30369533.176-12%30369533.176-12%
Usd Price Per Share1.970+11%1.7603.920-55%4.625-62%2.011-12%2.011-12%
Usd Profit---3181000.000-4067000.000+28%-2634500.000-17%-2582397.059-19%-2582397.059-19%
Usd Revenue----0%70554.000-100%16600.941-100%16600.941-100%
Usd Total Gains Per Share--0.009-0.170+1942%0.490-98%0.017-44%0.017-44%
 EOD+6 -2MRQTTM+16 -17YOY+5 -325Y+10 -2710Y+10 -27

3.3 Fundamental Score

Let's check the fundamental score of Intensity Therapeutics, Inc. Common stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.339
Price to Book Ratio (EOD)Between0-110.198
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.476
Current Ratio (MRQ)Greater than11.916
Debt to Asset Ratio (MRQ)Less than10.390
Debt to Equity Ratio (MRQ)Less than10.639
Return on Equity (MRQ)Greater than0.15-1.090
Return on Assets (MRQ)Greater than0.05-0.665
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Intensity Therapeutics, Inc. Common stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.859
Ma 20Greater thanMa 502.056
Ma 50Greater thanMa 1002.163
Ma 100Greater thanMa 2002.300
OpenGreater thanClose1.980
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Intensity Therapeutics, Inc. Common stock

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Fundamental data was last updated by Penke on 2025-04-05 04:53:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Intensity Therapeutics, Inc. Common stock earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Intensity Therapeutics, Inc. Common stock to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-280.9%+280.9%
TTM-5Y-66.1%+66.1%
5Y-66.1%10Y-66.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--109.6%+109.6%
TTM--185.9%+185.9%
YOY-280.9%-206.2%-74.7%
5Y-66.1%-399.1%+333.0%
10Y-66.1%-522.9%+456.8%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Intensity Therapeutics, Inc. Common stock is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Intensity Therapeutics, Inc. Common stock to theΒ Biotechnology industry mean.
  • -66.5% Return on Assets means thatΒ Intensity Therapeutics, Inc. Common stock generatedΒ $-0.67 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is -66.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -57.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-66.5%TTM-57.1%-9.4%
TTM-57.1%YOY-48.2%-8.8%
TTM-57.1%5Y-54.3%-2.7%
5Y-54.3%10Y-54.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.5%-14.2%-52.3%
TTM-57.1%-14.6%-42.5%
YOY-48.2%-14.4%-33.8%
5Y-54.3%-15.5%-38.8%
10Y-54.3%-18.0%-36.3%
4.3.1.3. Return on Equity

Shows how efficient Intensity Therapeutics, Inc. Common stock is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Intensity Therapeutics, Inc. Common stock to theΒ Biotechnology industry mean.
  • -109.0% Return on Equity means Intensity Therapeutics, Inc. Common stock generated $-1.09Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is -109.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -93.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-109.0%TTM-93.9%-15.1%
TTM-93.9%YOY-15.8%-78.1%
TTM-93.9%5Y-25.8%-68.1%
5Y-25.8%10Y-25.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-109.0%-17.5%-91.5%
TTM-93.9%-17.9%-76.0%
YOY-15.8%-19.1%+3.3%
5Y-25.8%-24.3%-1.5%
10Y-25.8%-26.0%+0.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Intensity Therapeutics, Inc. Common stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Intensity Therapeutics, Inc. Common stock is operatingΒ .

  • Measures how much profit Intensity Therapeutics, Inc. Common stock makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Intensity Therapeutics, Inc. Common stock to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-280.9%+280.9%
TTM-5Y-66.1%+66.1%
5Y-66.1%10Y-66.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.7%+223.7%
TTM--281.1%+281.1%
YOY-280.9%-226.6%-54.3%
5Y-66.1%-393.2%+327.1%
10Y-66.1%-503.6%+437.5%
4.3.2.2. Operating Ratio

Measures how efficient Intensity Therapeutics, Inc. Common stock is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2.970-2.970
TTM-5Y0.699-0.699
5Y0.69910Y0.6990.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.324-2.324
TTM-3.192-3.192
YOY2.9703.069-0.099
5Y0.6995.100-4.401
10Y0.6996.912-6.213
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Intensity Therapeutics, Inc. Common stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Intensity Therapeutics, Inc. Common stock is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.92Β means the company has $1.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is 1.916. The company is able to pay all its short-term debts. +1
  • The TTM is 2.577. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.916TTM2.577-0.660
TTM2.577YOY8.224-5.647
TTM2.5775Y3.229-0.652
5Y3.22910Y3.2290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9163.776-1.860
TTM2.5773.930-1.353
YOY8.2244.470+3.754
5Y3.2295.748-2.519
10Y3.2296.099-2.870
4.4.3.2. Quick Ratio

Measures if Intensity Therapeutics, Inc. Common stock is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Intensity Therapeutics, Inc. Common stock to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.48Β means the company can pay off $1.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is 1.476. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.747. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.476TTM2.747-1.271
TTM2.747YOY11.315-8.569
TTM2.7475Y3.974-1.228
5Y3.97410Y3.9740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4763.102-1.626
TTM2.7473.367-0.620
YOY11.3154.358+6.957
5Y3.9745.731-1.757
10Y3.9746.427-2.453
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Intensity Therapeutics, Inc. Common stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Intensity Therapeutics, Inc. Common stockΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Intensity Therapeutics, Inc. Common stock to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.39Β means that Intensity Therapeutics, Inc. Common stock assets areΒ financed with 39.0% credit (debt) and the remaining percentage (100% - 39.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is 0.390. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.364. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.390TTM0.364+0.026
TTM0.364YOY4.560-4.195
TTM0.3645Y3.065-2.700
5Y3.06510Y3.0650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3900.340+0.050
TTM0.3640.340+0.024
YOY4.5600.318+4.242
5Y3.0650.364+2.701
10Y3.0650.393+2.672
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Intensity Therapeutics, Inc. Common stock is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Intensity Therapeutics, Inc. Common stock to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 63.9% means that company has $0.64 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The MRQ is 0.639. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.603. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.639TTM0.603+0.036
TTM0.603YOY0.144+0.460
TTM0.6035Y0.176+0.428
5Y0.17610Y0.1760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6390.400+0.239
TTM0.6030.407+0.196
YOY0.1440.389-0.245
5Y0.1760.428-0.252
10Y0.1760.460-0.284
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Intensity Therapeutics, Inc. Common stock generates.

  • Above 15 is considered overpriced butΒ always compareΒ Intensity Therapeutics, Inc. Common stock to theΒ Biotechnology industry mean.
  • A PE ratio of -2.09 means the investor is paying $-2.09Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The EOD is -2.339. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.089. Based on the earnings, the company is expensive. -2
  • The TTM is -3.546. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.339MRQ-2.089-0.249
MRQ-2.089TTM-3.546+1.457
TTM-3.546YOY-5.680+2.134
TTM-3.5465Y-2.171-1.375
5Y-2.17110Y-2.1710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.339-1.736-0.603
MRQ-2.089-2.674+0.585
TTM-3.546-3.220-0.326
YOY-5.680-3.337-2.343
5Y-2.171-6.386+4.215
10Y-2.171-7.280+5.109
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The EOD is -2.788. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.491. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.753. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.788MRQ-2.491-0.297
MRQ-2.491TTM-3.753+1.262
TTM-3.753YOY-32.825+29.072
TTM-3.7535Y-8.606+4.854
5Y-8.60610Y-8.6060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.788-2.260-0.528
MRQ-2.491-3.714+1.223
TTM-3.753-4.332+0.579
YOY-32.825-4.468-28.357
5Y-8.606-8.682+0.076
10Y-8.606-9.845+1.239
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Intensity Therapeutics, Inc. Common stock is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 9.11 means the investor is paying $9.11Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Intensity Therapeutics, Inc. Common stock:

  • The EOD is 10.198. Based on the equity, the company is expensive. -2
  • The MRQ is 9.111. Based on the equity, the company is overpriced. -1
  • The TTM is 12.950. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.198MRQ9.111+1.087
MRQ9.111TTM12.950-3.839
TTM12.950YOY4.888+8.062
TTM12.9505Y4.197+8.753
5Y4.19710Y4.1970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.1981.608+8.590
MRQ9.1112.269+6.842
TTM12.9502.443+10.507
YOY4.8882.468+2.420
5Y4.1973.790+0.407
10Y4.1974.287-0.090
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Intensity Therapeutics, Inc. Common stock.

4.8.1. Institutions holding Intensity Therapeutics, Inc. Common stock

Institutions are holding 18.009% of the shares of Intensity Therapeutics, Inc. Common stock.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Armistice Capital, LLC7.45140.0271112686811268680
2024-12-31Vanguard Group Inc1.3813020888600
2024-12-31Brown Advisory Holdings Inc0.86010.0003130072-18037-12.1782
2024-12-31Geode Capital Management, LLC0.425506434900
2024-12-31Sigma Planning Corp0.36260.00354837709314.8563
2024-12-31Blair William & Co0.250.00023780500
2024-12-31One Charles Private Wealth Services, LLC0.21030.01883180000
2024-12-31BlackRock Inc0.14710222521390.6286
2024-12-31Mesirow Fin Investmt Mgmt Intl Equity0.13230.000720000-24177-54.7276
2024-12-31Lakeview Capital Partners, LLC0.11520.00681742000
2024-12-31Citadel Advisors Llc0.0989014964149640
2024-12-31State Street Corp0.095901450000
2024-12-31Stonebridge Financial Group, LLC0.05490.0016830183010
2024-12-31UBS Group AG0.0203021-17588-85.3414
2024-12-31Tower Research Capital LLC0.01750.000126481479126.5184
2024-12-31Morgan Stanley - Brokerage Accounts0.0033050000
2024-12-31Bank of America Corp0.000305012.0408
2024-12-31JPMorgan Chase & Co0.0001017-17-50
2024-12-31Wells Fargo & Co000-3450-100
2024-12-31Sentinus, LLC000-18918-100
Total 11.62670.05861758290+1076658+61.2%

4.9.2. Funds holding Intensity Therapeutics, Inc. Common stock

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-02-28Vanguard Total Stock Mkt Idx Inv1.256901900722177312.9371
2025-02-28Vanguard Institutional Extnd Mkt Idx Tr0.26840.00014058700
2025-01-31Fidelity Extended Market Index0.22160.000233513-509-1.4961
2025-02-28iShares Micro-Cap ETF0.13210.00531998400
2025-01-31Fidelity Total Market Index0.06230942100
2025-01-31Fidelity Series Total Market Index0.05380814100
2025-01-31Fidelity Nasdaq Composite Index0.04570.0001691700
2024-12-31NT Ext Equity Mkt Idx Fd - NL0.03940.0002595300
2025-01-31Spartan Extended Market Index Pool E0.03270.0002494550911.4743
2024-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03120.00024718-78-1.6264
2024-12-31NT Ext Equity Mkt Idx Fd - L0.02180.0001329400
2024-12-31Northern Trust Extended Eq Market Idx0.02180.0001329400
2025-01-311290 VT Micro Cap K0.01220.0024185100
2025-01-31Spartan Total Market Index Pool E0.00920139300
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.00520.00017857850
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.00520.00017857850
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00340.000250810.1972
2024-12-31Northern Trust Wilshire 50000.0017025000
2025-01-31Fidelity U.S. Equity Index Ins Trust0.000101900
Total 2.22470.0093336430+23266+6.9%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,783
Total Liabilities1,865
Total Stockholder Equity2,918
 As reported
Total Liabilities 1,865
Total Stockholder Equity+ 2,918
Total Assets = 4,783

Assets

Total Assets4,783
Total Current Assets3,363
Long-term Assets1,420
Total Current Assets
Cash And Cash Equivalents 2,590
Other Current Assets 773
Total Current Assets  (as reported)3,363
Total Current Assets  (calculated)3,363
+/-0
Long-term Assets
Property Plant Equipment 122
Long-term Assets Other 1,298
Long-term Assets  (as reported)1,420
Long-term Assets  (calculated)1,420
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,755
Long-term Liabilities110
Total Stockholder Equity2,918
Total Current Liabilities
Short-term Debt 28
Accounts payable 1,219
Other Current Liabilities 508
Total Current Liabilities  (as reported)1,755
Total Current Liabilities  (calculated)1,755
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt110
Long-term Liabilities  (as reported)110
Long-term Liabilities  (calculated)110
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -66,783
Other Stockholders Equity 69,699
Total Stockholder Equity (as reported)2,918
Total Stockholder Equity (calculated)2,918
+/-0
Other
Capital Stock2
Cash and Short Term Investments 2,590
Common Stock Shares Outstanding 13,856
Liabilities and Stockholders Equity 4,783
Net Debt -2,452
Net Invested Capital 2,918
Net Working Capital 1,608
Property Plant and Equipment Gross 122
Short Long Term Debt Total 138



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
10,150
0
0
8,109
5,216
3,725
2,274
1,205
1,757
951
18,228
16,816
17,295
12,408
8,673
5,213
4,783
4,7835,2138,67312,40817,29516,81618,2289511,7571,2052,2743,7255,2168,1090010,150
   > Total Current Assets 
9,628
0
0
7,698
4,730
3,269
1,877
853
1,450
745
18,060
16,635
15,464
11,169
7,440
3,787
3,363
3,3633,7877,44011,16915,46416,63518,0607451,4508531,8773,2694,7307,698009,628
       Cash And Cash Equivalents 
9,316
0
0
7,408
4,539
3,042
1,722
697
1,312
617
136
6,694
8,556
7,458
3,241
2,782
2,590
2,5902,7823,2417,4588,5566,6941366171,3126971,7223,0424,5397,408009,316
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
8,955
6,220
3,039
3,083
0
0
003,0833,0396,2208,95500000000000
       Net Receivables 
54
0
0
47
51
64
68
56
62
72
17,765
14
0
0
0
0
0
000001417,765726256686451470054
       Inventory 
217
0
0
172
70
151
60
0
29
39
0
957
0
0
0
0
0
00000957039290601517017200217
       Other Current Assets 
41
0
0
71
69
14
27
100
47
18
159
14
688
672
1,116
1,005
773
7731,0051,116672688141591847100271469710041
   > Long-term Assets 
522
0
0
411
486
456
397
352
307
206
168
181
1,831
1,239
1,233
1,426
1,420
1,4201,4261,2331,2391,83118116820630735239745648641100522
       Property Plant Equipment 
490
0
0
362
318
274
229
185
139
39
0
153
147
141
135
128
122
12212813514114715303913918522927431836200490
       Long-term Assets Other 
32
0
0
50
168
182
168
168
168
168
168
28
1,684
1,098
1,098
1,298
1,298
1,2981,2981,0981,0981,68428168168168168168182168500032
> Total Liabilities 
11,708
0
0
14,648
13,900
14,501
14,755
5,419
16,854
16,914
3,094
905
4,133
2,686
3,328
2,434
1,865
1,8652,4343,3282,6864,1339053,09416,91416,8545,41914,75514,50113,90014,6480011,708
   > Total Current Liabilities 
1,346
0
0
4,421
3,721
4,368
4,670
5,383
6,818
6,878
3,058
724
3,959
2,519
3,204
2,317
1,755
1,7552,3173,2042,5193,9597243,0586,8786,8185,3834,6704,3683,7214,421001,346
       Short-term Debt 
171
0
0
2,181
2,199
2,216
2,234
2,252
4,492
4,517
0
11
40
26
54
28
28
28285426401104,5174,4922,2522,2342,2162,1992,18100171
       Short Long Term Debt 
0
0
0
0
0
0
0
0
4,349
4,478
0
0
0
0
0
0
0
00000004,4784,34900000000
       Accounts payable 
223
0
0
295
173
540
463
796
603
899
1,582
358
3,048
1,219
1,919
540
1,219
1,2195401,9191,2193,0483581,58289960379646354017329500223
       Other Current Liabilities 
952
0
0
1,945
1,349
1,612
1,972
2,335
1,723
1,461
1,477
355
871
1,274
1,231
1,749
508
5081,7491,2311,2748713551,4771,4611,7232,3351,9721,6121,3491,94500952
   > Long-term Liabilities 
10,362
0
0
10,227
10,180
10,132
10,084
36
10,036
10,036
36
181
174
167
124
117
110
1101171241671741813610,03610,0363610,08410,13210,18010,2270010,362
       Other Liabilities 
0
0
0
0
0
0
0
36
0
36
36
0
0
0
0
0
0
00000036360360000000
> Total Stockholder Equity
-1,558
0
0
-6,539
-8,684
-10,776
-12,480
-4,214
-15,097
-15,962
15,134
15,911
13,162
9,722
5,345
2,779
2,918
2,9182,7795,3459,72213,16215,91115,134-15,962-15,097-4,214-12,480-10,776-8,684-6,53900-1,558
   Common Stock
1
0
0
1
1
1
1
1
0
0
1
1
1
1
1
1
2
21111110011111001
   Retained Earnings -66,783-63,602-60,089-55,118-50,515-47,343-45,014-39,989-38,653-37,143-35,368-33,440-31,071-28,67000-23,176
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
21,616
0
0
22,130
22,386
22,663
22,887
22,928
23,555
24,027
60,145,764
63,253
46,381
64,839
65,433
66,380
69,699
69,69966,38065,43364,83946,38163,25360,145,76424,02723,55522,92822,88722,66322,38622,1300021,616



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-16,585
Operating Income-16,585-16,585
 
Operating Expense (+$)
Research Development10,496
Selling General Administrative6,089
Selling And Marketing Expenses0
Operating Expense16,58516,585
 
Net Interest Income (+$)
Interest Income314
Interest Expense-0
Other Finance Cost-0
Net Interest Income314
 
Pretax Income (+$)
Operating Income-16,585
Net Interest Income314
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,268-16,902
EBIT - interestExpense = 0
-16,268
-16,268
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-16,268
Earnings Before Interest and Taxes (EBITDA)-16,585
 
After tax Income (+$)
Income Before Tax-16,268
Tax Provision-0
Net Income From Continuing Ops-16,268-16,268
Net Income-16,268
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net317-314
 

Technical Analysis of Intensity Therapeutics, Inc. Common stock
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Intensity Therapeutics, Inc. Common stock. The general trend of Intensity Therapeutics, Inc. Common stock is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Intensity Therapeutics, Inc. Common stock's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Intensity Therapeutics, Inc. Common stock Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Intensity Therapeutics, Inc. Common stock.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.43 < 2.4996 < 2.5322.

The bearish price targets are: 1.77 > 1.73 > 1.5.

Know someone who trades $INTS? Share this with them.πŸ‘‡

Intensity Therapeutics, Inc. Common stock Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Intensity Therapeutics, Inc. Common stock. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Intensity Therapeutics, Inc. Common stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Intensity Therapeutics, Inc. Common stock. The current macd is -0.0744215.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Intensity Therapeutics, Inc. Common stock price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Intensity Therapeutics, Inc. Common stock. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Intensity Therapeutics, Inc. Common stock price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Intensity Therapeutics, Inc. Common stock Daily Moving Average Convergence/Divergence (MACD) ChartIntensity Therapeutics, Inc. Common stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Intensity Therapeutics, Inc. Common stock. The current adx is 34.48.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Intensity Therapeutics, Inc. Common stock shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Intensity Therapeutics, Inc. Common stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Intensity Therapeutics, Inc. Common stock. The current sar is 2.34252932.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Intensity Therapeutics, Inc. Common stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Intensity Therapeutics, Inc. Common stock. The current rsi is 43.86. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Intensity Therapeutics, Inc. Common stock Daily Relative Strength Index (RSI) ChartIntensity Therapeutics, Inc. Common stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Intensity Therapeutics, Inc. Common stock. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Intensity Therapeutics, Inc. Common stock price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Intensity Therapeutics, Inc. Common stock Daily Stochastic Oscillator ChartIntensity Therapeutics, Inc. Common stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Intensity Therapeutics, Inc. Common stock. The current cci is -61.49619454.

Intensity Therapeutics, Inc. Common stock Daily Commodity Channel Index (CCI) ChartIntensity Therapeutics, Inc. Common stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Intensity Therapeutics, Inc. Common stock. The current cmo is -10.77662829.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Intensity Therapeutics, Inc. Common stock Daily Chande Momentum Oscillator (CMO) ChartIntensity Therapeutics, Inc. Common stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Intensity Therapeutics, Inc. Common stock. The current willr is -55.26315789.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Intensity Therapeutics, Inc. Common stock is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Intensity Therapeutics, Inc. Common stock Daily Williams %R ChartIntensity Therapeutics, Inc. Common stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Intensity Therapeutics, Inc. Common stock.

Intensity Therapeutics, Inc. Common stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Intensity Therapeutics, Inc. Common stock. The current atr is 0.19043944.

Intensity Therapeutics, Inc. Common stock Daily Average True Range (ATR) ChartIntensity Therapeutics, Inc. Common stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Intensity Therapeutics, Inc. Common stock. The current obv is 34,037,766.

Intensity Therapeutics, Inc. Common stock Daily On-Balance Volume (OBV) ChartIntensity Therapeutics, Inc. Common stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Intensity Therapeutics, Inc. Common stock. The current mfi is 45.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Intensity Therapeutics, Inc. Common stock Daily Money Flow Index (MFI) ChartIntensity Therapeutics, Inc. Common stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Intensity Therapeutics, Inc. Common stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Intensity Therapeutics, Inc. Common stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Intensity Therapeutics, Inc. Common stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.859
Ma 20Greater thanMa 502.056
Ma 50Greater thanMa 1002.163
Ma 100Greater thanMa 2002.300
OpenGreater thanClose1.980
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Intensity Therapeutics, Inc. Common stock with someone you think should read this too:
  • Are you bullish or bearish on Intensity Therapeutics, Inc. Common stock? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Intensity Therapeutics, Inc. Common stock? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Intensity Therapeutics, Inc. Common stock

I send you an email if I find something interesting about Intensity Therapeutics, Inc. Common stock.


Comments

How you think about this?

Leave a comment

Stay informed about Intensity Therapeutics, Inc. Common stock.

Receive notifications about Intensity Therapeutics, Inc. Common stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.